Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Aaronson

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|November 30, 2018
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseasesWhitney Shatz, Jeffrey Aaronson, Stefan Yohe, et al.
Toxicologic Pathology|November 30, 2020
Tolerability Assessment of Formulation pH in New Zealand White Rabbits Following Intravitreal AdministrationNardos G Tassew, Steven T Laing, Jeffrey Aaronson, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|November 30, 2018
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseasesWhitney Shatz, Jeffrey Aaronson, Stefan Yohe, et al.
Toxicologic Pathology|November 30, 2020
Tolerability Assessment of Formulation pH in New Zealand White Rabbits Following Intravitreal AdministrationNardos G Tassew, Steven T Laing, Jeffrey Aaronson, et al.
Pageof 1